BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/24/2022 2:32:33 PM | Browse: 201 | Download: 364
 |
Received |
|
2021-10-30 04:42 |
|
Peer-Review Started |
|
2021-10-30 04:42 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-02-14 06:58 |
|
Revised |
|
2022-03-04 13:33 |
|
Second Decision |
|
2022-03-22 06:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-03-26 21:45 |
|
Articles in Press |
|
2022-03-26 21:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-04-19 09:03 |
|
Publish the Manuscript Online |
|
2022-05-24 14:32 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Bone flare after initiation of novel hormonal therapy in patients with metastatic hormone-sensitive prostate cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ke-Hao Li, Yuan-Cheng Du, Dong-Yu Yang, Xin-Yuan Yu, Xue-Ping Zhang, Yong-Xiang Li and Liang Qiao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Liang Qiao, MD, PhD, Chief Doctor, Professor, Department of Urology, Weifang People's Hospital, No. 151 Guangwen Street, Kuiwen District, Weifang 261000, Shandong Province, China. lysanjin@163.com |
| Key Words |
Bone flare; Novel hormonal therapy; Metastatic hormone-sensitive prostate cancer; Apalutamide; Case report |
| Core Tip |
In 2018, prostate cancer was ranked as the fifth leading cause of cancer-related deaths in men, worldwide. Some of such cases are metastatic hormone-sensitive prostate cancers (mHSPC) and Apalutamide has been shown to improve survival in such patients. However, a “bone-flare” phenomenon may occur during management with apalutamide. We describe a case of mHSPC with this phenomenon after apalutamide and androgen deprivation therapy, and thus demonstrate the importance of multiple bone imaging modalities, radionuclide bone imaging, magnetic resonance imaging, prostate-specific antigen, prostate-specific membrane antigen positron emission tomography – computed tomography, in determining the treatment course in such patients. |
| Publish Date |
2022-05-24 14:32 |
| Citation |
Li KH, Du YC, Yang DY, Yu XY, Zhang XP, Li YX, Qiao L. Bone flare after initiation of novel hormonal therapy in patients with metastatic hormone-sensitive prostate cancer: A case report. World J Clin Cases 2022; 10(15): 4985-4990 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i15/4985.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i15.4985 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
